Redefining the Value of Diagnostics in a Changing Payment Environment

Share this Article
Facebook
Twitter
Email
LinkedIn
Google+

Redefining the Value of Diagnostics in a Changing Payment Environment

Please join Charles Mathews, Vice President, Boston Healthcare Associates, as he shares insights into how laboratorians can better frame the value of the testing services they provide to payers and hospital administration along with identifying tools to secure value-based funds for testing.

Assessing the Financial Impact of Your DMT

Measure the value of your Diagnostic Management Team by quantifying its financial impact on your organization

Generating Revenue for Your Organization Through DMT Interpretations

Demonstrate the value of your DMT by generating revenue and results for your organization

LabLeaders.com has a new home. Tell us a bit about yourself.

First Name

Last Name

Mobile Phone Number

Thank you!

Error - something went wrong!

No thanks

Other content in this pillar

Making an Evidence-Based Financial Case for Investment in Lab Quality with CoPQ

Redefining the Value of Diagnostics in a Changing Payment Environment

Redefining the Value of Diagnostics in a Changing Payment Environment

Previous Article

Next Article

Other content in this pillar

More than ever, healthcare service lines need to be strategic in how they pursue opportunities to avoid excessive spending.

Understanding what is in your organization's strategic plan can help your lab team focus its efforts and deliver value in the best way. Here's how to tie your initiatives to the plan.

A series designed to help you understand, calculate and reduce your cost of poor quality.

Striving for quality over quantity can help your lab save money and achieve better patient outcomes. Checkout provide helpful tips and advice on how to take your lab from a cost center to a cost saver

In this video, Charles Mathews, vice president of Boston Healthcare, explains how to convince payers of the value of your testing, amid the changing role of diagnostics.

Measure the value of your Diagnostic Management Team by quantifying its financial impact on your organization

Demonstrate the value of your DMT by generating revenue and results for your organization

Les Duncan discusses changing reimbursement models and how the lab can prove it is a valuable asset to the highest level of administration.

Lab leaders from some of the nation's most respected health systems describe how their operations work with clinicians and IT to become integral members of the care team.

Lab leaders must be able to demonstrate growth and ROI to the C-suite. Learn how with three fundamental steps.

While lab leaders strive to implement new standards of care, it can be a challenge to get paid for such initiatives. Our Lab Leaders explain how labs can maximize their chances of success.

Discover the strategies one lab employs for better contract negotiations with payers and ACOs.

Review a quick guide to collaboration that can jump-start your collaborative efforts today

Discover the hidden potential of common predictive biomarkers to bring lost patients back to care.

Most laboratories fall short when it comes to addressing the bottom line. Here’s why you need to think about finances—and how you can get started.

LabLeaders examines the expected impact of new clinical laboratory payment rates set to go into effect on Jan. 1, and how labs can prepare for the change with operational improvement initiatives.

This underutilized cost of quality metric, known as Cost of Poor Quality (CoPQ), can help you demonstrate ROI for your lab.

Jennifer Dawson discusses the concept of Cost of Poor Quality and its components.

Lab leaders discuss how to use data and analytics to turn the lab from a cost center into a strategic partner in value-based care

In-house labs can dramatically amplify their value by making themselves good business partners, not just good clinical partners. Here are some "how-tos" from the nation's top lab leaders.